Clinical Outcomes of COVID-19 in Patients with Multiple Sclerosis Treated with Ocrelizumab in the Pre- and Post-Sars-cov-2 Vaccination Periods: Insights from Israel
Multiple sclerosis and related disorders(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要